| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |